Literature DB >> 28881319

Acute effects of intravenous cocaine administration on serum concentrations of ghrelin, amylin, glucagon-like peptide-1, insulin, leptin and peptide YY and relationships with cardiorespiratory and subjective responses.

Sofia Bouhlal1, Kayla N Ellefsen2, Mikela B Sheskier1, Erick Singley3, Sandrine Pirard2, David A Gorelick2, Marilyn A Huestis2, Lorenzo Leggio4.   

Abstract

BACKGROUND: Food intake and use of drugs of abuse like cocaine share common central and peripheral physiological pathways. Appetitive hormones play a major role in regulating food intake; however, little is known about the effects of acute cocaine administration on the blood concentrations of these hormones in cocaine users.
METHODS: We evaluated serum concentrations of six appetitive hormones: ghrelin (total and acyl-ghrelin), amylin, glucagon-like peptide-1 (GLP-1), insulin, leptin and peptide YY (PYY), as well as acute cardiorespiratory and subjective responses of 8 experienced cocaine users who received 25mg intravenous (IV) cocaine.
RESULTS: Serum concentrations of GLP-1 (p=0.014) and PYY (p=0.036) were significantly decreased one hour following IV cocaine administration; there was a trend towards a decrease for insulin (p=0.055) and amylin (p=0.063) concentrations, while no significant IV cocaine effect was observed for ghrelin (total or acyl-ghrelin) or leptin concentrations (p's≫>0.5). We also observed associations between hormone concentrations acutely affected by IV cocaine (GLP-1, PYY, insulin, amylin) and some cocaine-related cardiorespiratory and subjective responses (e.g., increased heart and respiratory rates; feeling high and anxious). DISCUSSION: These findings show a significant effect of acute IV cocaine administration on some appetitive hormones and suggest potential associations between these hormones and cocaine-related cardiorespiratory and subjective responses. Additional research is needed to further investigate the potential mechanisms underlining these associations. Published by Elsevier B.V.

Entities:  

Keywords:  Appetitive hormones; Cardiorespiratory responses; IV cocaine administration; Subjective responses

Mesh:

Substances:

Year:  2017        PMID: 28881319      PMCID: PMC5654385          DOI: 10.1016/j.drugalcdep.2017.07.033

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  63 in total

Review 1.  Insulin: understanding its action in health and disease.

Authors:  P Sonksen; J Sonksen
Journal:  Br J Anaesth       Date:  2000-07       Impact factor: 9.166

2.  Using Effect Size-or Why the P Value Is Not Enough.

Authors:  Gail M Sullivan; Richard Feinn
Journal:  J Grad Med Educ       Date:  2012-09

Review 3.  Hormonal and neural mechanisms of food reward, eating behaviour and obesity.

Authors:  Susan Murray; Alastair Tulloch; Mark S Gold; Nicole M Avena
Journal:  Nat Rev Endocrinol       Date:  2014-06-24       Impact factor: 43.330

4.  Overlapping patterns of brain activation to food and cocaine cues in cocaine abusers: association to striatal D2/D3 receptors.

Authors:  Dardo Tomasi; Gene-Jack Wang; Ruiliang Wang; Elisabeth C Caparelli; Jean Logan; Nora D Volkow
Journal:  Hum Brain Mapp       Date:  2014-08-21       Impact factor: 5.038

Review 5.  The role of the central ghrelin system in reward from food and chemical drugs.

Authors:  Suzanne L Dickson; Emil Egecioglu; Sara Landgren; Karolina P Skibicka; Jörgen A Engel; Elisabet Jerlhag
Journal:  Mol Cell Endocrinol       Date:  2011-02-24       Impact factor: 4.102

Review 6.  Role of leptin in blood pressure regulation and arterial hypertension.

Authors:  Jerzy Bełtowski
Journal:  J Hypertens       Date:  2006-05       Impact factor: 4.844

7.  Reciprocal Inhibitory Interactions Between the Reward-Related Effects of Leptin and Cocaine.

Authors:  Zhi-Bing You; Bin Wang; Qing-Rong Liu; Yan Wu; Laszlo Otvos; Roy A Wise
Journal:  Neuropsychopharmacology       Date:  2015-08-05       Impact factor: 7.853

8.  GLP-1 analog attenuates cocaine reward.

Authors:  D L Graham; K Erreger; A Galli; G D Stanwood
Journal:  Mol Psychiatry       Date:  2012-10-23       Impact factor: 15.992

9.  The glucagon-like peptide 1 analogue, exendin-4, attenuates the rewarding properties of psychostimulant drugs in mice.

Authors:  Emil Egecioglu; Jörgen A Engel; Elisabet Jerlhag
Journal:  PLoS One       Date:  2013-07-16       Impact factor: 3.240

10.  The skinny on cocaine: insights into eating behavior and body weight in cocaine-dependent men.

Authors:  Karen D Ersche; Jan Stochl; Jeremy M Woodward; Paul C Fletcher
Journal:  Appetite       Date:  2013-08-03       Impact factor: 3.868

View more
  10 in total

Review 1.  Central GLP-1 receptors: Novel molecular targets for cocaine use disorder.

Authors:  N S Hernandez; H D Schmidt
Journal:  Physiol Behav       Date:  2019-03-28

2.  Can anti-obesity drugs be repurposed to treat cocaine addiction?

Authors:  David J Reiner; Jennifer M Bossert
Journal:  Neuropsychopharmacology       Date:  2018-04-17       Impact factor: 7.853

Review 3.  GLP-1: Molecular mechanisms and outcomes of a complex signaling system.

Authors:  Nicholas K Smith; Troy A Hackett; Aurelio Galli; Charles R Flynn
Journal:  Neurochem Int       Date:  2019-04-17       Impact factor: 3.921

Review 4.  The role of glucagon-like peptide 1 (GLP-1) in addictive disorders.

Authors:  Mette Kruse Klausen; Morgane Thomsen; Gitta Wortwein; Anders Fink-Jensen
Journal:  Br J Pharmacol       Date:  2022-02       Impact factor: 9.473

5.  Testing the effects of the GLP-1 receptor agonist exenatide on cocaine self-administration and subjective responses in humans with cocaine use disorder.

Authors:  Gustavo A Angarita; David Matuskey; Brian Pittman; Jessica L Costeines; Marc N Potenza; Ania M Jastreboff; Heath D Schmidt; Robert T Malison
Journal:  Drug Alcohol Depend       Date:  2021-02-15       Impact factor: 4.492

6.  Involvement of the ghrelin system in the maintenance and reinstatement of cocaine-motivated behaviors: a role of adrenergic action at peripheral β1 receptors.

Authors:  Zhi-Bing You; Ewa Galaj; Francisco Alén; Bin Wang; Guo-Hua Bi; Allamar R Moore; Tristram Buck; Madeline Crissman; Sruti Pari; Zheng-Xiong Xi; Lorenzo Leggio; Roy A Wise; Eliot L Gardner
Journal:  Neuropsychopharmacology       Date:  2021-12-18       Impact factor: 8.294

7.  Substance Use Affects Type 1 Diabetes Pancreas Pathology: Implications for Future Studies.

Authors:  Brittany S Bruggeman; Martha Campbell-Thompson; Stephanie L Filipp; Matthew J Gurka; Mark A Atkinson; Desmond A Schatz; Laura M Jacobsen
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-29       Impact factor: 6.055

8.  Leptin Protects Against the Development and Expression of Cocaine Addiction-Like Behavior in Heterogeneous Stock Rats.

Authors:  Lieselot L G Carrette; Cristina Corral; Brent Boomhower; Molly Brennan; Caitlin Crook; Clara Ortez; Kokila Shankar; Sierra Simpson; Lisa Maturin; Leah C Solberg Woods; Abraham A Palmer; Giordano de Guglielmo; Olivier George
Journal:  Front Behav Neurosci       Date:  2022-03-03       Impact factor: 3.558

Review 9.  The Role of Ghrelin/GHS-R1A Signaling in Nonalcohol Drug Addictions.

Authors:  Magdalena Sustkova-Fiserova; Chrysostomos Charalambous; Anna Khryakova; Alina Certilina; Marek Lapka; Romana Šlamberová
Journal:  Int J Mol Sci       Date:  2022-01-11       Impact factor: 5.923

10.  An Overview of Appetite-Regulatory Peptides in Addiction Processes; From Bench to Bed Side.

Authors:  Olesya T Shevchouk; Maximilian Tufvesson-Alm; Elisabet Jerlhag
Journal:  Front Neurosci       Date:  2021-12-09       Impact factor: 4.677

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.